Combination therapy commonly used with Entyvio, Stelara

Combination therapy commonly used with Entyvio, Stelara

Entyvio and Stelara were commonly used in combination therapy for the treatment of inflammatory bowel disease, according to research at Digestive Disease Week.“When used with an immunomodulator (ie, azathioprine, methotrexate), anti-TNFs are associated with lower rates of anti-drug antibodies and increased rates of clinical remission but also with increased rates of infections,” Megan Lutz, MD, fellow at the University of Wisconsin School of Medicine and Public Health, told Healio Gastroenterology. “[Entyvio (vedolizumab, Takeda)] and [Stelara (ustekinumab, Janssen)] areRead More

Share on facebook
Share on twitter
Share on linkedin